https://t.co/GpCr54xmf9 "Agomelatine is an antagonist targeting the postsynaptic serotonin receptor 5-HT2c and melatonergic receptor agonist (MT1/MT2)." "Agomelatine has been approved for the treatment of MDD."
3,927 followers
3,927 followers
Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive disorder #MECFS #LongCovid https://t.co/GpCr54xmf9
574 followers
OL trial: After 9 weeks of treatment with agomelatine in MDD patients, the remission rates were 39.7%. Somatic symptoms and the HAMD anhedonia items improved (both, p<0.001). Also, the ASEX score (sexual dysfunction) dropped (p<0.001) https://t.co/TX
36 followers
RT @FrontPsychiatry: New Research: Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive…